A detailed history of Stance Capital LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Stance Capital LLC holds 45,994 shares of EW stock, worth $3.97 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
45,994
Previous 9,722 373.09%
Holding current value
$3.97 Million
Previous $760 Million 370.43%
% of portfolio
1.31%
Previous 0.29%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 18, 2025

BUY
$73.75 - $81.83 $2.68 Million - $2.97 Million
36,272 Added 373.09%
45,994 $3.58 Billion
Q2 2025

Aug 22, 2025

BUY
$67.07 - $78.22 $652,054 - $760,454
9,722 New
9,722 $760 Million
Q4 2024

Apr 14, 2025

BUY
$64.54 - $75.92 $1.49 Million - $1.76 Million
23,148 New
23,148 $1.71 Billion

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $53.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Stance Capital LLC Portfolio

Follow Stance Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stance Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stance Capital LLC with notifications on news.